XML 75 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Reportable Operating Segments (Tables)
12 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Schedule of business segments information
Reportable operating segment information with a reconciliation to the consolidated statements of comprehensive income (loss) is summarized as follows:
 
Years Ended March 31,
 
2018
 
2017
 
2016
Net sales to external customers:
 
 
 
 
 
UGG brand wholesale
$
841,893

 
$
826,355

 
$
918,102

Teva brand wholesale
117,478

 
103,694

 
121,239

Sanuk brand wholesale
78,283

 
77,552

 
90,719

Other brands wholesale
149,961

 
116,206

 
100,820

Direct-to-Consumer
715,724

 
666,340

 
644,317

 
$
1,903,339

 
$
1,790,147

 
$
1,875,197

Income (loss) from operations:
 
 
 
 
 
UGG brand wholesale
$
247,826

 
$
213,407

 
$
246,990

Teva brand wholesale
20,400

 
10,045

 
17,692

Sanuk brand wholesale
14,474

 
(110,582
)
 
15,565

Other brands wholesale
22,258

 
1,571

 
(4,384
)
Direct-to-Consumer
156,896

 
109,802

 
101,756

Unallocated overhead costs
(239,270
)
 
(226,162
)
 
(215,492
)
 
$
222,584

 
$
(1,919
)
 
$
162,127


 
Years Ended March 31,
 
2018
 
2017
 
2016
Depreciation, amortization and accretion:
 
 
 
 
 
UGG brand wholesale
$
3,193

 
$
3,167

 
$
2,254

Teva brand wholesale
12

 
24

 
54

Sanuk brand wholesale
4,174

 
5,018

 
6,556

Other brands wholesale
865

 
971

 
1,101

Direct-to-Consumer
13,396

 
15,669

 
19,030

Unallocated overhead costs
26,932

 
27,779

 
21,029

 
$
48,572

 
$
52,628

 
$
50,024

Capital expenditures:
 
 
 
 
 
UGG brand wholesale
$
58

 
$
3,444

 
$
1,458

Teva brand wholesale

 

 

Sanuk brand wholesale
20

 

 
881

Other brands wholesale

 
191

 
51

Direct-to-Consumer
8,641

 
15,277

 
18,445

Unallocated overhead costs
26,094

 
25,587

 
45,351

 
$
34,813

 
$
44,499

 
$
66,186


Assets allocable to each reportable operating segment are as follows:
 
 
As of March 31,
 
 
2018
 
2017
Total assets from reportable operating segments:
 
 
 
 
UGG brand wholesale
 
$
229,894

 
$
259,444

Teva brand wholesale
 
85,980

 
82,505

Sanuk brand wholesale
 
79,322

 
80,102

Other brands wholesale
 
74,809

 
70,607

Direct-to-Consumer
 
112,355

 
113,400

 
 
$
582,360

 
$
606,058

Schedule of reconciliations of total assets from reportable segments to the condensed consolidated balance sheets
Total assets allocable to each reportable operating segment reconciled to the consolidated balance sheets are as follows:
 
 
As of March 31,
 
 
2018
 
2017
Total assets from reportable operating segments
 
$
582,360

 
$
606,058

Unallocated cash and cash equivalents
 
429,970

 
291,764

Unallocated deferred tax assets
 
38,381

 
44,708

Unallocated other corporate assets
 
213,668

 
249,250

Total assets
 
$
1,264,379

 
$
1,191,780